Molin Wang

Summary

Affiliation: Harvard University
Country: USA

Publications

  1. ncbi A semiparametric method for analyzing matched case-control family studies with a continuous outcome and proband sampling
    Molin Wang
    Department of Biostatistics, Harvard School of Public Health and Dana Farber Cancer Institute, Boston, Massachusetts 02115, USA
    Biometrics 60:644-50. 2004
  2. ncbi Generalization of the Mantel-Haenszel estimating function for sparse clustered binary data
    Molin Wang
    Department of Biostatistics, Harvard School of Public Health and Dana Farber Cancer Institute, Boston, Massachusetts 02115, USA
    Biometrics 61:973-81. 2005
  3. ncbi A simple imputation method for longitudinal studies with non-ignorable non-responses
    Molin Wang
    Department of Biostatistics, Harvard School of Public Health, Boston, MA 02115, USA
    Biom J 48:302-18. 2006
  4. ncbi A robust method for finely stratified familial studies with proband-based sampling
    Molin Wang
    Department of Biostatistics, Harvard School of Public Health and Dana Farber Cancer Institute, 44 Binney Street, Boston, MA 02115, USA
    Biostatistics 10:364-73. 2009
  5. ncbi Vitamin D status and incidence of pulmonary tuberculosis, opportunistic infections, and wasting among HIV-infected Tanzanian adults initiating antiretroviral therapy
    Christopher R Sudfeld
    Department of Epidemiology, Harvard School of Public Health, Brigham and Women s Hospital, Boston, Massachusetts, USA
    J Infect Dis 207:378-85. 2013
  6. ncbi Association of serum albumin concentration with mortality, morbidity, CD4 T-cell reconstitution among tanzanians initiating antiretroviral therapy
    Christopher R Sudfeld
    Department of Epidemiology, HarvardSchool of Public Health, Boston, Massachusetts, USA
    J Infect Dis 207:1370-8. 2013
  7. ncbi A proportional hazards cure model for the analysis of time to event with frequently unidentifiable causes
    Suzanne E Dahlberg
    Department of Biostatistics, Harvard School of Public Health and Dana Farber Cancer Institute, Boston, Massachusetts 02115, USA
    Biometrics 63:1237-44. 2007
  8. ncbi Prospective study of family history and colorectal cancer risk by tumor LINE-1 methylation level
    Shuji Ogino
    Center for Molecular Oncologic Pathology, Dana Farber Cancer Institute, Brigham and Women s Hospital, Harvard Medical School, 450 Brookline Ave, Rm JF 215C, Boston, MA 02215, USA
    J Natl Cancer Inst 105:130-40. 2013
  9. ncbi An accelerated failure time mixture cure model with masked event
    Jenny J Zhang
    Department of Biostatistics, Harvard School of Public Health, 655 Huntington Avenue, Boston, MA 02115, USA
    Biom J 51:932-45. 2009
  10. ncbi Latent class joint model of ovarian function suppression and DFS for premenopausal breast cancer patients
    Jenny J Zhang
    Department of Biostatistics, Harvard School of Public Health, 655 Huntington Avenue, Building 2, Boston, MA 02115, USA
    Stat Med 29:2310-24. 2010

Detail Information

Publications15

  1. ncbi A semiparametric method for analyzing matched case-control family studies with a continuous outcome and proband sampling
    Molin Wang
    Department of Biostatistics, Harvard School of Public Health and Dana Farber Cancer Institute, Boston, Massachusetts 02115, USA
    Biometrics 60:644-50. 2004
    ..We apply the proposed method to sleep apnea data. A simulation study demonstrates the usefulness of our approach...
  2. ncbi Generalization of the Mantel-Haenszel estimating function for sparse clustered binary data
    Molin Wang
    Department of Biostatistics, Harvard School of Public Health and Dana Farber Cancer Institute, Boston, Massachusetts 02115, USA
    Biometrics 61:973-81. 2005
    ..Analysis of the Georgia High Blood Pressure survey is used for illustration...
  3. ncbi A simple imputation method for longitudinal studies with non-ignorable non-responses
    Molin Wang
    Department of Biostatistics, Harvard School of Public Health, Boston, MA 02115, USA
    Biom J 48:302-18. 2006
    ..An appealing feature of the proposed method is that it can be readily implemented using existing, widely-available statistical software. The method is illustrated using longitudinal data on obesity from the MCRF study...
  4. ncbi A robust method for finely stratified familial studies with proband-based sampling
    Molin Wang
    Department of Biostatistics, Harvard School of Public Health and Dana Farber Cancer Institute, 44 Binney Street, Boston, MA 02115, USA
    Biostatistics 10:364-73. 2009
    ..An analytical standard error estimator for the proposed estimator is also provided. The proposed approach is applied to a matched case-control familial study of sleep apnea. A simulation study confirms the usefulness of the approach...
  5. ncbi Vitamin D status and incidence of pulmonary tuberculosis, opportunistic infections, and wasting among HIV-infected Tanzanian adults initiating antiretroviral therapy
    Christopher R Sudfeld
    Department of Epidemiology, Harvard School of Public Health, Brigham and Women s Hospital, Boston, Massachusetts, USA
    J Infect Dis 207:378-85. 2013
    ..We present the first prospective study of vitamin D among human immunodeficiency virus (HIV)-infected adults receiving antiretrovirals in sub-Saharan Africa...
  6. ncbi Association of serum albumin concentration with mortality, morbidity, CD4 T-cell reconstitution among tanzanians initiating antiretroviral therapy
    Christopher R Sudfeld
    Department of Epidemiology, HarvardSchool of Public Health, Boston, Massachusetts, USA
    J Infect Dis 207:1370-8. 2013
    ....
  7. ncbi A proportional hazards cure model for the analysis of time to event with frequently unidentifiable causes
    Suzanne E Dahlberg
    Department of Biostatistics, Harvard School of Public Health and Dana Farber Cancer Institute, Boston, Massachusetts 02115, USA
    Biometrics 63:1237-44. 2007
    ..The method is applied to data from a breast cancer clinical trial...
  8. ncbi Prospective study of family history and colorectal cancer risk by tumor LINE-1 methylation level
    Shuji Ogino
    Center for Molecular Oncologic Pathology, Dana Farber Cancer Institute, Brigham and Women s Hospital, Harvard Medical School, 450 Brookline Ave, Rm JF 215C, Boston, MA 02215, USA
    J Natl Cancer Inst 105:130-40. 2013
    ..We tested the hypothesis that CRC family history might confer a higher risk of LINE-1 methylation-low CRC...
  9. ncbi An accelerated failure time mixture cure model with masked event
    Jenny J Zhang
    Department of Biostatistics, Harvard School of Public Health, 655 Huntington Avenue, Boston, MA 02115, USA
    Biom J 51:932-45. 2009
    ..We also conduct a simulation study to evaluate the performance of the proposed method...
  10. ncbi Latent class joint model of ovarian function suppression and DFS for premenopausal breast cancer patients
    Jenny J Zhang
    Department of Biostatistics, Harvard School of Public Health, 655 Huntington Avenue, Building 2, Boston, MA 02115, USA
    Stat Med 29:2310-24. 2010
    ..We employ a likelihood approach and the EM algorithm to obtain parameter estimates and present results from the IBCSG data analysis...
  11. ncbi Vitamin D and HIV progression among Tanzanian adults initiating antiretroviral therapy
    Christopher R Sudfeld
    Department of Epidemiology, Harvard School of Public Health, Boston, Massachusetts, United States of America
    PLoS ONE 7:e40036. 2012
    ..There is growing evidence of an association between low vitamin D and HIV disease progression; however, no prospective studies have been conducted among adults receiving antiretroviral therapy (ART) in sub-Saharan Africa...
  12. ncbi Association of vascular endothelial growth factor and vascular endothelial growth factor receptor-2 genetic polymorphisms with outcome in a trial of paclitaxel compared with paclitaxel plus bevacizumab in advanced breast cancer: ECOG 2100
    Bryan P Schneider
    Indiana University School of Medicine, Indianapolis, IN, USA
    J Clin Oncol 26:4672-8. 2008
    ..Therefore, we evaluated the association of VEGF genotype with efficacy and toxicity in E2100, a phase III study comparing paclitaxel versus paclitaxel plus bevacizumab as initial chemotherapy for metastatic breast cancer...
  13. ncbi Weekly paclitaxel in the adjuvant treatment of breast cancer
    Joseph A Sparano
    Eastern Cooperative Oncology Group, Philadelphia, USA
    N Engl J Med 358:1663-71. 2008
    ..We compared the efficacy of two different taxanes, docetaxel and paclitaxel, given either weekly or every 3 weeks, in the adjuvant treatment of breast cancer...
  14. ncbi Paclitaxel plus bevacizumab versus paclitaxel alone for metastatic breast cancer
    Kathy Miller
    Indiana University Cancer Center, Indianapolis, USA
    N Engl J Med 357:2666-76. 2007
    ....
  15. ncbi Plasma matrix metalloproteinases 7 and 9 in patients with metastatic breast cancer treated with marimastat or placebo: Eastern Cooperative Oncology Group trial E2196
    Stanley Zucker
    Veterans Affairs Medical Center, Northport, NY State University Hospital of New York, Stony Brook, USA
    Clin Breast Cancer 6:525-9. 2006
    ..CONCLUSION: We conclude that measurement of plasma MMP-7 or MMP-9 levels, as performed in our trial, was not a useful prognostic or predictive factor in patients with MBC or in patients treated with an MMPI...